## Breast Cancer Prediction: Interpretable Machine Learning for Clinical Decision Support

### Project Overview

This project focuses on the development of a transparent and high-performing classification model for predicting whether a breast tumor is **malignant** or **benign**. The primary objective is to balance **predictive accuracy (F1-score > 0.95)** with **interpretability**, ensuring the model can be trusted and accepted in a clinical setting.

Using structured numerical tumor characteristics, the project demonstrates how interpretable machine learning techniques specifically Logistic Regression can provide both strong classification performance and clear explanatory insights for medical professionals.

The project follows the **CRISP-DM methodology**, ensuring a structured and reproducible data science workflow aligned with clinical and organizational requirements.

---

### Business Understanding & Goals

**Clinical Challenge (Trust & Transparency):**
Oncologists require not only accurate predictions but also understandable reasoning behind model decisions. Black-box models may achieve high performance but are often unsuitable for high-stakes medical environments.

**Primary Goals:**

* Achieve an **F1-score greater than 0.95**.
* Maintain full interpretability of model predictions.
* Provide clinically meaningful explanations of feature contributions.

**Key Requirements:**

* Transparent modeling approach.
* Robust performance on unseen test data.
* Clear communication of strengths and limitations.
* Conceptual integration into clinical workflow.

---

### Data Source

**Dataset:** Breast Cancer Wisconsin Diagnostic Dataset
**Instances:** 569 tumor samples
**Features:** 30 numerical tumor characteristics
**Target Variable:** Diagnosis (Malignant / Benign)

Key feature categories include:

* Tumor size (radius, perimeter, area)
* Shape irregularity (concavity, concave points)
* Texture and symmetry metrics

Class distribution:

* 357 benign cases
* 212 malignant cases

The dataset contains no missing feature values and is suitable for supervised classification.

---

### Methodology

The project followed a structured analytical workflow:

#### 1. Business Understanding

* Defined clinical objective.
* Established success criteria (F1 > 0.95 + interpretability).

#### 2. Data Understanding

* Assessed class distribution and moderate imbalance.
* Evaluated data quality (no missing values).
* Identified highly correlated features (multicollinearity risk).

#### 3. Data Preparation

* Removed non-informative column.
* Encoded target variable into binary format.
* Standardized features using z-score normalization.

#### 4. Modeling

* Selected **Logistic Regression** due to:

  * Coefficient interpretability
  * Acceptance in medical research
  * Transparent probabilistic outputs
* Applied stratified train-test split.
* Used evaluation metrics appropriate for imbalanced medical classification.

#### 5. Evaluation

Performance evaluated using:

* Precision
* Recall
* Accuracy
* F1-score
* Confusion Matrix
* ROC Curve

#### 6. Deployment Concept

* Designed a conceptual GUI.
* Proposed integration as a clinical decision support tool.
* Ensured model acts as complement not replacement to physicians.

---

### Model Performance

* **F1-score:** > 0.95 (requirement satisfied)
* High precision and recall across both classes.
* Strong discrimination between malignant and benign tumors.

The model demonstrates that high interpretability does not require sacrificing predictive performance.

---

### Model Interpretability & Clinical Insights

Logistic Regression provides interpretable coefficients that can be translated into **odds ratios**.

Key findings:

* Tumor size-related features (radius, perimeter, area) strongly increase malignancy probability.
* Shape irregularity metrics (concavity, concave points) are highly predictive of malignancy.
* Coefficient signs directly indicate direction of influence on malignancy probability.

This transparency enhances trustworthiness and supports informed clinical decisions.

---

### Error Analysis & Limitations

* Misclassifications may occur near decision boundaries.
* Logistic regression assumes a linear relationship between features and log-odds.
* False negatives (malignant predicted benign) represent higher clinical risk and must be carefully monitored.

Future work may include:

* Threshold optimization.
* External validation on independent datasets.
* Comparison with additional interpretable models (e.g., Decision Trees).

---

### Key Results & Achievements

* F1-score above required 0.95 threshold.
* Fully interpretable classification model.
* No missing values in modeling dataset.
* Structured workflow aligned with CRISP-DM.
* Conceptual deployment plan for clinical integration.
* Transparent communication of limitations and assumptions.


## Project Deliverables

* Interpretable Logistic Regression classification model.
* Fully documented analytical workflow.
* Evaluation metrics demonstrating high performance.
* Clinical interpretation of explanatory variables.
* Conceptual GUI design for deployment.
* Structured Git repository layout.

---

This project demonstrates how interpretable machine learning can be responsibly applied in high-stakes medical environments while maintaining both performance and transparency.
